Format

Send to

Choose Destination
HPB (Oxford). 2013 Sep;15(9):655-60. doi: 10.1111/hpb.12011. Epub 2012 Dec 27.

A comparison between patients with gastrointestinal stromal tumours diagnosed with isolated liver metastases and liver metastases plus sarcomatosis.

Author information

1
Department of Sarcoma Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.

Abstract

OBJECTIVES:

This study was conducted to compare overall survival (OS) in patients presenting with isolated hepatic metastases with that of patients with synchronous metastatic disease to the liver and sarcomatosis on a background of gastrointestinal stromal tumours (GISTs).

METHODS:

Patients presenting with metastatic GISTs during 1999-2009 were identified. Survival outcomes were compared between groups.

RESULTS:

Of the 193 patients with GISTs, 43 patients presented with isolated hepatic metastases and 16 presented with synchronous metastases to the liver and sarcomatosis. Thirteen patients with metastases to the liver and sarcomatosis underwent surgery, and 34 patients with metastatic disease solely to the liver underwent hepatic resection. The proportion of patients treated with preoperative tyrosine kinase inhibitor (TKI) therapy was similar in both groups. Similar OS was observed in both groups (isolated liver metastases group: 40.5 months; liver metastases and sarcomatosis group: 28.7 months; P = 0.620).

CONCLUSIONS:

Overall survival in patients with GIST and metastatic disease to the liver and sarcomatosis is similar to that in patients with isolated metastatic liver disease. Although patients with a greater disease burden might be expected to show worse survival, these data do not reflect this assumption.

PMID:
23458233
PMCID:
PMC3948531
DOI:
10.1111/hpb.12011
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center